Mucosal Melanoma Clinical Trials
0 recruiting
Showing 1–5 of 5 trials
Recruiting
Phase 2
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
Recurrent Mucosal MelanomaMucosal MelanomaAnal Melanoma+14 more
National Cancer Institute (NCI)101 enrolled147 locationsNCT05111574
Recruiting
Phase 1
A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma
Melanoma MetastaticMucosal MelanomaUveal Melanoma, Metastatic
Alpha-9 Oncology USA Inc.50 enrolled4 locationsNCT07076550
Recruiting
Phase 2
Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation)
Cutaneous MelanomaMucosal Melanoma
Melanoma Institute Australia494 enrolled1 locationNCT06999980
Recruiting
Phase 2
Axitinib and Nivolumab for the Treatment of Mucosal Melanoma
Mucosal Melanoma
Memorial Sloan Kettering Cancer Center20 enrolled2 locationsNCT05384496
Recruiting
Phase 2
Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery
Mucosal MelanomaPD-L1 Positive
The First Hospital of Jilin University220 enrolled1 locationNCT07400302